Satria Oryza, Aprilya Dina
Department of Orthopaedic and Traumatology, Fatmawati General Hospital - Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
Orthop Res Rev. 2025 Aug 19;17:401-412. doi: 10.2147/ORR.S506375. eCollection 2025.
Peripheral nerve injury (PNI) is characterized by poor functional outcomes, insufficient nerve regeneration, and deterioration of sensory and motor function. Factors such as nerve tissue loss and extended denervation of proximal nerves impede regeneration. Therapeutic interventions include microsurgical techniques and nerve-guide conduits. However, nerve adhesion, which restricts nerve mobility, also contributes to inadequate healing. Surgical modifications and chemical agents are used to mitigate adhesion.
We searched across four databases, PubMed, Cochrane Database of Systematic Reviews, EMBASE, and Medline, using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. The study quality and risk of bias were assessed using the systematic review center for laboratory animal experimentation (SYRCLE)'s and Cochrane RoB-2 tools.
Out of 549 studies, 5 studies met our inclusion criteria, consisting of four animal studies and one randomized controlled trial involving human participants. Different nerve adhesion materials were evaluated in the studies included. Histological evaluation of nerve regeneration generally shows more advanced regenerative hallmarks in the intervention group. Additionally, in terms of motor and sensory function, improvements were seen in the majority of parameters observed in all studies included.
This systematic review indicates that nerve adhesion barriers show promising outcomes in promoting nerve regeneration and functional recovery by reducing adhesion and enhancing structural alignment in peripheral nerve injuries. Applicability of such barriers in humans may still be debatable as findings are limited by the small number of included studies and predominance of animal data. Further long-term trials may warrant its' clinical efficacy.
周围神经损伤(PNI)的特点是功能预后差、神经再生不足以及感觉和运动功能退化。神经组织损失和近端神经长期失神经支配等因素会阻碍神经再生。治疗干预措施包括显微外科技术和神经引导导管。然而,限制神经移动性的神经粘连也会导致愈合不充分。手术改良和化学药剂被用于减轻粘连。
我们按照系统评价和荟萃分析的首选报告项目(PRISMA)2020指南,在四个数据库,即PubMed、Cochrane系统评价数据库、EMBASE和Medline中进行检索。使用实验室动物实验系统评价中心(SYRCLE)的工具和Cochrane RoB-2工具评估研究质量和偏倚风险。
在549项研究中,有5项研究符合我们的纳入标准,包括4项动物研究和1项涉及人类参与者的随机对照试验。纳入的研究中评估了不同的神经粘连材料。神经再生的组织学评估通常显示干预组有更先进的再生特征。此外,在运动和感觉功能方面,所有纳入研究中观察到的大多数参数都有改善。
本系统评价表明,神经粘连屏障通过减少粘连和增强周围神经损伤中的结构排列,在促进神经再生和功能恢复方面显示出有前景的结果。由于研究结果受纳入研究数量少和动物数据占主导的限制,此类屏障在人类中的适用性可能仍有争议。进一步的长期试验可能证明其临床疗效。